2nd IPO this year by a Philadelphia-area life sciences company, and the 5th since late October, is expected this week

Posted on February 27, 2020 — Jessica Jones Gupta

Passage Bio, a Philadelphia gene therapy startup spun out of the University of Pennsylvania, is set to go public Friday. The company plans to sell 7.4 million shares of its common stock at between $16 and $18 per share, according to documents it filed with the Securities and Exchange Commission. Read more on the Philadelphia…

Scrap metal-powered lights win Y-Prize 2020

Posted on February 26, 2020 — Jessica Jones Gupta

The winning team, Metal Light, proposes technology to provide illumination for houses not connected to electrical grids. Each year, Penn Engineering, Wharton’s Mack Institute for Innovation Management, Penn Wharton Entrepreneurship and the Penn Center for Innovation team up to host the Y-Prize at Penn, an invention competition in which entrants are challenged to pitch an innovative business…

View the Innovation @ Penn Schedule for SXSW 2020

Posted on February 25, 2020 — Jessica Jones Gupta

PCI is excited to once again be a Tradeshow Exhibitor at SXSW and support the efforts of Amplify Philly. If you will be in Austin, check out our Booth #622 and visit the Amplify Philly House Startups to Meet at Booth #622 Sunday, March 15 10:30am – 2:30pm: Exyn Technologies, FulPhil + Cocoa Press 2:30pm – 4:30pm: Atlas, THRIVE + Alphagora…

Here’s what Amplify Philly, now a nonprofit, has planned for SXSW 2020

Posted on February 24, 2020 — Jessica Jones Gupta

The city’s official presence at Austin’s annual conference/festival/cultural hub is its own independent entity, though it’s still getting lots of support from local stakeholders, including former fiscal sponsor Philly Startup Leaders. This year’s sponsors include the likes of returning bigwigs Comcast, CHOP and the City of Philadelphia (read about the Philadelphia Global Identity Partnership’s branding efforts in the Philly…

This isn’t a ‘biotech bubble,’ it’s ‘Philadelphia’s moment’ to become a center for gene therapy, says Penn-based CEO

Posted on — Jessica Jones Gupta

Smart, small biotech companies — dozens in the U.S. over the last two years, including several in the Philadelphia area — have gone public before they’ve made a profit, a sale, or even a product. Is too much money chasing too few winners? Will this end like the dot.com blowup of 2001? “This is not…

Penn’s Dr. Jean Bennett is the Life Sciences PA 2020 Scientific Achievement Award Winner

Posted on February 19, 2020 — Jessica Jones Gupta

Dr. Jean Bennett has been named the recipient of the Life Sciences PA Scientific Achievement Award, to be presented during the Life Sciences PA Annual Dinner March 19 at the Pennsylvania Convention Center in Philadelphia. The Life Sciences PA Scientific Achievement Award recognizes a scientist in the Pennsylvania life sciences community who has demonstrated outstanding achievement by…

Pinpoint Therapeutics raises $1 Million seed round led by Kairos Ventures

Posted on February 12, 2020 — Jessica Jones Gupta

Pinpoint Therapeutics, Inc. (“Pinpoint”), a privately held biopharmaceutical company focused on the development of novel autophagy inhibitors to treat cancer, announced today that it has raised $1 million in debt financing led by Kairos Ventures of Beverly Hills, California. Read More on Yahoo Finance

Cutting-edge CRISPR gene editing appears safe in three cancer patients

Posted on February 7, 2020 — Jessica Jones Gupta

Launching a new chapter in the fast-moving cancer immunotherapy field, scientists have blended two cutting-edge approaches: CRISPR, which edits DNA, and T cell therapy, in which sentries of the immune system are exploited to destroy tumors. Two women and one man, all in their 60s—one with sarcoma and two with the blood cancer multiple myeloma—received…

Penn gene therapy pioneer Jim Wilson’s Passage Bio plans IPO

Posted on February 4, 2020 — Jessica Jones Gupta

Philadelphia-based Passage Bio plans to raise as much as $125 million selling stock shares to the public through an initial public offering (IPO), the Philadelphia-based firm told the Securities and Exchange Commission in a public filing Monday. Passage Bio, based on gene therapy technology developed by University of Pennsylvania biotech pioneer James Wilson, says it will…